Justice Ginsburg Hospitalized for Gallbladder Ailment, Supreme Court Says
(Bloomberg) -- Justice Ruth Bader Ginsburg underwent non-surgical treatment for a benign gallbladder condition and will be in the hospital for a day or two, the U.S. Supreme Court said, in the latest health scare for its oldest justice.
Ginsburg, 87, a four-time cancer survivor, had been suffering from a gallstone which caused an infection, according to a statement from the court. She is “resting comfortably,” the court said, and plans to take part in two arguments Wednesday, which are being conducting by telephone because of the coronavirus.
Ginsburg was treated Tuesday at Johns Hopkins Hospital in Baltimore after undergoing tests the previous day at Sibley Memorial Hospital in Washington. She had participated in phone arguments on both days, taking turns with her colleagues in asking questions.
The court said the tests confirmed that a gallstone had migrated to Ginsburg's cystic duct, blocking it and causing the infection. Her condition, cholecystitis, is caused in most cases by gallstones blocking the tube leading out of the gallbladder, according to the Mayo Clinic's website.
Cholecystitis would typically call for a laparoscopic cholecycstecomy, a surgical procedure to remove the gallbladder, said Benjamin Thomson, head of general surgery at the Royal Melbourne Hospital in Australia. In an 87-year-old patient, antibiotic therapy may be recommended instead, he said.
Endoscopic Examination?
If the stone is causing cholangitis, or inflammation of the bile duct system, doctors may want to examine Ginsburg's pancreatic and bile ducts using an endoscope, said Thomson, a hepato-pancreato-biliary surgeon who treats pancreatic cancer. The so-called ERCP procedure would use a bendable, lighted tube placed through her mouth and into the stomach and first part of the small intestine. She'd also be administered antibiotics, he said.
Ginsburg reportedly had a distal pancreatectomy in the past, said Thomson, who has never treated her. “Normally that has a survival of only 1%, so it's amazing she's still alive,” he said.
Ginsburg's health has been of particular concern to liberals in recent years. The Supreme Court could tack sharply to the right if she had to step down and President Donald Trump was able to appoint her successor.
Read More: Supreme Court Tele-Argument Brings Minor Hiccups, Thomas Queries
Until last year, when she was recovering from lung-cancer surgery, Ginsburg had never missed an argument because of illness. She joined the court in 1993.
Ginsburg has also survived two bouts of early-stage pancreatic cancer, last year and in 2009, and was treated for colon cancer in 1999.
An avid exerciser, Ginsburg has continued with her workouts at the court even while much of Washington has been shut down because of the Covid-19 outbreak.
©2020 Bloomberg L.P.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.
-
Indians Are Travelling, But Not Every Journey Is A Holiday | The Week In Whys
Pilgrims, patients and working women are the real travellers, and the system hasn't quite caught up with them.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.